Neurogene (NGNE) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.22
-1.15
-1.07
-1

Details

Expected EPS
-1.1598
Actual EPS
-1.05
Surprise EPS
0.11
Surprise Percent
+9.47%

Description

Neurogene (NGNE) has reported earnings of -1.05 per share for Q3 2025.

0 Comments

Share your thoughts